Skip to content

Survey study, 2022

What causes PMDD symptoms and how can they be treated?

Low progesterone is linked to PMDD symptoms. A medication called allopregnanolone and certain foods may help reduce symptoms.

Early or limited evidence Literature review - not a study of specific women

What they did

Reviewed scientific literature and personal experience to understand how PMDD develops and what the physical and emotional symptoms are.

What they found

Low progesterone correlated with negative mood and physical symptoms in different phases of the menstrual cycle. Allopregnanolone (a type of medication) may reduce PMDD symptoms, and specific nutritional sources can help.

What it means for you

Doctors should understand how low progesterone causes PMDD and how allopregnanolone works as a treatment. This is a literature review rather than a study of actual patients, so the evidence is limited.

About the study

Original title
Every month: The result of premenstrual dysphoric disorders
Authors
Edna Aurelus
Journal
International Journal of Scientific Research Updates
Year
2022
Study design
Survey study
What was tested
Allopregnanolone and nutritional sources
Open access
Yes
Original abstract

Methods: Research was conducted using self-experience along with scientific literature findings to fully understand the physical and emotional syndromes of premenstrual dysphoric disorders (PMDD). Findings: Correlation with low progesterone in relation to negative affective and physical symptoms during the follicle and luteal phase were observed. Allopregnanolone, a neurosteroid, as a therapeutic agent can alleviate PMDD symptoms. Specific nutritional sources can also help alleviating the presenting symptoms. Conclusion: Awareness about PMDD symptoms is warranted in women experiencing them. Providers need to be familiar of the emotional and physical effect of low progesterone and the mechanism of action of Allopregnanolone in treating PMDD, when other interventions such as psychotherapy and other pharmacological intervention failed.

Reproduced under CC-BY.

Topics